NK cell Activation

Natural Killer (NK) cell activation is controlled by a dynamic balance between complementary and antagonistic pathways that are initiated upon interaction with potential target cells. Here is the latest research.

January 16, 2022
Open Access

Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy.

Molecular Cancer
Reza HosseiniNahid Eskandari
January 16, 2022
Open Access

Functional genomics analysis identifies T and NK cell activation as a driver of epigenetic clock progression.

Genome Biology
Thomas H JonkmanBastiaan T Heijmans
January 14, 2022

Eomes and T-bet, a dynamic duo regulating NK cell differentiation.

BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology
Jiang ZhangThierry Walzer
January 12, 2022
Open Access

Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy.

Konstantinos ArvanitakisGeorgios Germanidis
January 12, 2022
Open Access

The Micro-Immunotherapy Medicine 2LEID Exhibits an Immunostimulant Effect by Boosting Both Innate and Adaptive Immune Responses.

International Journal of Molecular Sciences
Camille JacquesIlaria Floris
January 12, 2022
Open Access

Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors.

International Journal of Molecular Sciences
Guangyu LianHui-Yao Lan
January 12, 2022
Open Access

Infections, Reactions of Natural Killer T Cells and Natural Killer Cells, and Kidney Injury.

International Journal of Molecular Sciences
Takahiro UchidaTakashi Oda
January 12, 2022
Open Access

Ubiquitin Activating Enzyme UBA6 Regulates Th1 and Tc1 Cell Differentiation.

Ji Yeon LeePeter C W Lee
January 12, 2022
Open Access

Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology.

Journal of Hematology & Oncology
No-Joon SongZihai Li
January 12, 2022

NKG7 Is Required for Optimal Antitumor T-cell Immunity.

Cancer Immunology Research
Xian-Yang LiChristian R Engwerda
January 10, 2022

Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway.

International Immunopharmacology
Hui-Yang WuYu-Xian Huang
January 8, 2022

Role of Fcγ receptors in HER2-targeted breast cancer therapy.

Journal for Immunotherapy of Cancer
Antonino MusolinoMark D Pegram
January 7, 2022
Open Access

Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses

BioRxiv : the Preprint Server for Biology
S. G. DosilL. Fernandez-Messina
January 7, 2022

Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease.

The Journal of Immunology : Official Journal of the American Association of Immunologists
Taru S DuttElizabeth P Ryan

Sign up to follow this feed and discover related papers.

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

© 2022 Meta ULC. All rights reserved